|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
16.400 -0.720 (-4.206%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 6.406% | 9.445% | 9.284% | 7.254% | 7.511% |
| ROAE (%) | 9.020% | 13.131% | 12.825% | 10.129% | 9.758% |
| Return on Capital Employed (%) | 6.947% | 10.983% | 9.471% | 6.903% | 6.882% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 40.083% | 44.038% | 46.928% | 45.132% | 41.641% |
| EBITDA Margin (%) | 32.281% | 41.639% | 45.455% | 42.478% | 35.682% |
| Pre-tax Profit Margin (%) | 24.502% | 35.090% | 38.806% | 35.025% | 28.281% |
| Net Profit Margin (%) | 19.958% | 28.950% | 32.930% | 30.092% | 25.449% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.776 X | 1.982 X | 2.366 X | 3.158 X | 3.369 X |
| Quick Ratio (X) | 2.545 X | 1.737 X | 2.161 X | 2.917 X | 3.229 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 22.197% | 26.937% | 25.723% | 27.843% | 26.736% |
| Total Debt / Total Assets (%) | 8.062% | 8.921% | 9.755% | 11.504% | 12.464% |
| Net Debt / Total Assets (%) | -9.029% | -3.982% | -10.692% | -12.995% | -22.790% |
| Total Debt / Shareholders' Funds (%) | 11.310% | 12.616% | 13.307% | 16.203% | 17.161% |
| Long Term Debt / Shareholders' Funds (%) | 9.496% | 8.421% | 6.412% | 12.177% | 12.995% |
| Net Debt / Shareholders' Funds (%) | -12.666% | -5.631% | -14.585% | -18.302% | -31.379% |
| Net Cash / (Debt) ($) | 5.108B | 1.974B | 4.708B | 3.764B | 4.012B |
| Net Cash / (Debt) per share ($) | 1.200 | 0.467 | 1.105 | 0.921 | 1.033 |
| Total Debt / Capital Employed (%) | 9.320% | 10.987% | 12.006% | 13.619% | 14.893% |
| Interest Coverage Ratio (X) | 27.335 X | 84.218 X | 102.889 X | 47.002 X | 58.467 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 72.358 Day | 84.756 Day | 92.620 Day | 87.924 Day | 49.186 Day |
| Receivables Turnover (Day) | 110.882 Day | 93.295 Day | 97.316 Day | 119.773 Day | 96.193 Day |
| Payables Turnover (Day) | 17.438 Day | 16.879 Day | 22.414 Day | 27.048 Day | 18.636 Day |
| Remarks: | Real time quote last updated: 11/11/2024 10:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,499,080 |
| %Change | -33.864% |
| EPS / (LPS) | RMB 0.370 |
| NBV Per Share (¥) | RMB 9.789 |